Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism CCL5 inhibitors(C-C motif chemokine 5 inhibitors), CCR3 antagonists(C-C chemokine receptor type 3 antagonists), eotaxin-1 inhibitors(Eotaxin inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Discovery | IL | - |